Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1α-mediated glycolytic adaptation

Journal of Virology

Volumn 84, Issue 1, 2010, Pages 647-660

  Ripoli, Maria ^a   D'Aprile, Annamaria ^a   Quarato, Giovanni ^a   Sarasin Filipowicz, Magdalena ^b   Gouttenoire, Jérôme ^c   Scrima, Rosella ^a   Cela, Olga ^a   Boffoli, Domenico ^a   Heim, Markus H ^b   Moradpour, Darius ^c   Capitanio, Nazzareno ^a   Piccoli, Claudia ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLYCOLYTIC ENZYME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OLIGOMYCIN; PYRUVIC ACID; VIRUS PROTEIN;

ALPHA CHAIN; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLYCOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; METABOLITE; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; TRANSCRIPTION INITIATION; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; ANTIOXIDANTS; CELL LINE, TUMOR; GLYCOLYSIS; HEPACIVIRUS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; PROTEIN STABILITY; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 72849136940     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00769-09     Document Type: Article

References (52)

1. Abdalla, M. Y., I. M. Ahmad, D. R. Spitz, W. N. Schmidt, and B. E. Britigan. 2005. Hepatitis C virus-core and nonstructural proteins lead to different effects on cellular antioxidant defenses. J. Med. Virol. 76:489-497.
2. Appel, N., T. Schaller, F. Penin, and R. Bartenschlager. 2006. From structure to function: new insights into hepatitis C virus RNA replication. J. Biol. Chem. 281:9833-9836.
3. Blight, K. J., J. A. McKeating, and C. M. Rice. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76:13001-13014.
4. Brass, V., E. Bieck, R. Montserret, B. Wölk, J. A. Hellings, H. E. Blum, F. Penin, and D. Moradpour. 2002. An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J. Biol. Chem. 277:8130-8139.
5. Brune, B., and J. Zhou. 2007. Hypoxia-inducible factor-1 alpha under the control of nitric oxide. Methods Enzymol. 435:463-478.
6. Dery, M. A., M. D. Michaud, and D. E. Richard. 2005. Hypoxia-inducible factor 1: regulation of hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol. 37:535-540.
7. Firth, J. D., B. L. Ebert, and P. J. Ratcliffe. 1995. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270:21021-21027.
8. Fong, G. H., and K. Takeda. 2008. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 15:635-641.
9. Fukuda, R., K. Hirota, F. Fan, Y. D. Jung, L. M. Ellis, and G. L. Semenza. 2002. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277:38205-38211.
10. Hanauske-Abel, H. M., and A. M. Popowicz. 2003. The HAG mechanism: a molecular rationale for the therapeutic application of iron chelators in human diseases involving the 2-oxoacid utilizing dioxygenases. Curr. Med. Chem. 10:1005-1019.
11. Hara, H., H. Aizaki, M. Matsuda, F. Shinkai-Ouchi, Y. Inoue, K. Murakami, I. Shoji, H. Kawakami, M. M. Lai, T. Miyamura, T. Wakita, and T. Suzuki. 2009. Involvment of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein. J. Virol. 83:5137-5147.
12. Hervouet, E., A. Cízková, J. Demont, A. Vojtísková, P. Pecina, N. L. Franssen- van Hal, J. Keijer, H. Simonnet, R. Ivánek, S. Kmoch, C. Godinot, and J. Houstek. 2008. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 29:1528-1537.
13. Karhausen, J., T. Kong, S. Narravula, and S. P. Colgan. 2005. Induction of the von Hippel-Lindau tumor suppressor gene by late hypoxia limits HIF-1 expression. J. Cell Biochem. 95:1264-1275. (Pubitemid 41420132)
14. Kenneth, N. S., S. Mudie, P. van Uden, and S. Rocha. 2009. SWI/SNF regulates the cellular response to hypoxia. J. Biol. Chem. 284:4123-4131.
15. King, A., M. A. Selak, and E. Gottlieb. 2006. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25:4675-4682. (Pubitemid 44187617)
16. Koivunen, P., M. Hirsilä, A. M. Remes, I. E. Hassinen, K. I. Kivirikko, and J. Myllyharju. 2007. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J. Biol. Chem. 282:4524-4532.
17. Kolykhalov, A. A., E. V. Agapov, K. J. Blight, K. Mihalik, S. M. Feinstone, and C. M. Rice. 1997. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570-574. (Pubitemid 27369006)
18. Leslie, N. R. 2006. The redox regulation of PI 3-kinase-dependent signaling. Antioxid. Redox Signal. 8:1765-1774.
19. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wölk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. (Pubitemid 41033648)
20. Levrero, M. 2006. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834-3847. (Pubitemid 43980479)
21. Li, Y., D. F. Boehning, T. Qian, V. L. Popov, and S. A. Weinman. 2007. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J. 21:2474-2485. (Pubitemid 47230677)
22. Linster, C. L., and E. Van Schaftingen. 2007. Biosynthesis, recycling and degradation in mammals. FEBS J. 274:1-22.
23. López-Lázaro, M. 2008. Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med. Chem. 8:305-312. (Pubitemid 351761435)
24. Lu, H., C. L. Dalgard, A. Mohyeldin, T. McFate, A. S. Tait, and A. Verma. 2005. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280:41928-41939.
25. Maxwell, P. H. 2005. Hypoxia-inducible factor as a physiological regulator. Exp. Physiol. 90:791-797.
26. Moradpour, D., C. Englert, T. Wakita, and J. R. Wands. 1996. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222:51-63. (Pubitemid 26281358)
27. Moradpour, D., P. Kary, C. M. Rice, and H. E. Blum. 1998. Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 28:192-201. (Pubitemid 28300001)
28. Moradpour, D., F. Penin, and C. M. Rice. 2007. Replication of hepatitis C virus. Nat. Rev. Microbiol. 5:453-463.
29. Nasimuzzaman, M., G. Waris, D. Mikolon, D. G. Stupack, and A. Siddiqui. 2007. Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J. Virol. 81:10249-10257. (Pubitemid 47463300)
30. Pantano, C., N. L. Reynaert, A. van der Vliet, and Y. M. Janssen-Heininger. 2006. Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid. Redox. Signal. 8:1791-1806.
31. Piccoli, C., G. Quarato, M. Ripoli, A. D'Aprile, R. Scrima, O. Cela, D. Boffoli, D. Moradpour, and N. Capitanio. 2008. HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. Biochim. Biophys. Acta. doi:10.1016/j.bbabio.2008.11.008.
32. Piccoli, C., R. Scrima, A. D'Aprile, M. Ripoli, L. Lecce, D. Boffoli, and N. Capitanio. 2006. Mitochondrial dysfunction in hepatitis C virus infection. Biochim. Biophys. Acta 1757:1429-1437.
33. Piccoli, C., R. Scrima, G. Quarato, A. D'Aprile, M. Ripoli, L. Lecce, D. Boffoli, D. Moradpour, and N. Capitanio. 2007. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 46:58-65. (Pubitemid 47171921)
34. Rankin, E. B., and A. J. Giaccia. 2008. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15:678-685.
35. Rossignol, R., R. Gilkerson, R. Aggeler, K. Yamagata, S. J. Remington, and R. A. Capaldi. 2004. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64:985-993. (Pubitemid 38176901)
36. Schaller, T., N. Appel, G. Koutsoudakis, S. Kallis, V. Lohmann, T. Pietschmann, and R. Bartenschlager. 2007. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J. Virol. 81:4591-4603. (Pubitemid 46668657)
37. Schmidt-Mende, J., E. Bieck, T. Hugle, F. Penin, C. M. Rice, H. E. Blum, and D. Moradpour. 2001. Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J. Biol. Chem. 276:44052-44063.
38. Schofield, C. J., and P. J. Ratcliffe. 2004. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5:343-354.
39. Schwer, B., S. Ren, T. Pietschmann, J. Kartenbeck, K. Kaehlcke, R. Bartenschlager, T. S. Yen, and M. Ott. 2004. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J. Virol. 78:7958-7968. (Pubitemid 38944281)
40. Semela, D., and J. F. Dufour. 2004. Angiogenesis and hepatocellular carcinoma. J. Hepatol. 41:864-880.
41. Semenza, G. L., P. H. Roth, H. M. Fang, and G. L. Wang. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:23757-23763.
42. Semenza, G. L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3:721-732.
43. Shepard, C. W., L. Finelli, and M. J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5:558-567.
44. Storz, P. 2005. Reactive oxygen species in tumor progression. Front. Biosci. 10:1881-1896.
45. Tanaka, H., M. Yamamoto, N. Hashimoto, M. Miyakoshi, S. Tamakawa, M. Yoshie, Y. Tokusashi, K. Yokoyama, Y. Yaginuma, and K. Ogawa. 2006. Hypoxia-independent overexpression of hypoxia-inducible factor 1 alpha as an early change in mouse hepatocarcinogeesis. Cancer Res. 66:11263-11270. (Pubitemid 46009955)
46. Tanimoto, K., Y. Makino, T. Pereira, and L. Poellinger. 2000. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19:4298-4309. (Pubitemid 30623741)
47. Tardif, K. D., G. Waris, and A. Siddiqui. 2005. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 13:159-163.
48. van Uden, P., N. S. Kenneth, and S. Rocha. 2008. Regulation of hypoxiainducible factor-1alpha by NF-kappaB. Biochem. J. 412:477-484.
49. Walenta, S., T. Schroeder, and W. Mueller-Klieser. 2004. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr. Med. Chem. 16:2195-2204.
50. Warburg, O. 1956. On respiratory impairment in cancer cells. Science 124: 269-270.
51. Wölk, B., D. Sansonno, H. G. Kräusslich, F. Dammacco, C. M. Rice, H. E. Blum, and D. Moradpour. 2000. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J. Virol. 74:2293-2304.
52. Yoo, Y. G., S. H. Oh, E. S. Park, H. Cho, N. Lee, H. Park, D. K. Kim, D. Y. Yu, J. K. Seong, and M. O. Lee. 2003. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1 alpha through activation of mitogen-activated protein kinase pathway. J. Biol. Chem. 278:39076-39084.